D. Allard

发表

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

J. Weissenbach, N. Seidah, C. Junien, 2003, Nature Genetics.

The UMD‐LDLR database: additions to the software and 490 new entries to the database

Christophe Béroud, Mathilde Varret, Jean-Pierre Rabès, 2002, Human mutation.

Novel mutations of the PCSK9 gene cause variable phenotype of autosomal dominant hypercholesterolemia

C. Junien, M. Krempf, G. Luc, 2005, Human mutation.

Heterozygous TGFBR2 mutations in Marfan syndrome

Yusuke Nakamura, Naomichi Matsumoto, Mathilde Varret, 2004, Nature Genetics.

Regulation of RNA polymerase III transcription during transformation of human IMR90 fibroblasts with defined genetic elements

R. Roeder, F. Chibon, P. Lagarde, 2018, Cell cycle.

ZYMOGEN CLEAVAGE AND EFFECTS ON THE LOW DENSITY LIPOPROTEIN (LDL) RECEPTOR AND LDL CHOLESTEROL

A. Prat, N. Seidah, D. Rader, 2004 .

Cystathionine beta synthase: gene dosage effect in trisomy 21.

M. Rethoré, O. Raoul, D. Allard, 1985, Biochemical and biophysical research communications.

Assignment of human phosphoribosylglycinamide synthetase locus to region 21q221

M. Rethoré, O. Raoul, D. Allard, 2004, Human Genetics.

Bovine adrenal medullary chromogranin A: studies on the structure and further evidence for identity with dopamine-beta-hydroxylase subunit.

P. Mandel, D. Aunis, D. Allard, 1975, Biochimica et biophysica acta.

Adrenaline storage in the pronephros of the plaice, Pleuronectes platessa L.

D. Allard, D. Grove, C. Starr, 1972, Comparative and general pharmacology.

Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma

N. Sonenberg, A. Eggermont, J. Adam, 2018, Nature Medicine.

NARC-1/PCSK9 and Its Natural Mutants

A. Prat, N. Seidah, D. Rader, 2004, Journal of Biological Chemistry.

GENE DOSAGE EFFECT IN TRISOMY 21

J. Lejeune, P. Sinet, D. Allard, 1975, The Lancet.

eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies

A. Eggermont, C. Robert, N. Ribeiro, 2014, Nature.

Mercury exposure and risks from dental amalgam in the US population, post-2000.

G. M. Richardson, D. Allard, R. Wilson, 2011, The Science of the total environment.

IS ABSENCE OF ATHEROMA IN DOWN SYNDROME DUE TO DECREASED HOMOCYSTEINE LEVELS?

P. Kamoun, M. Coudé, D. Allard, 1988, The Lancet.

A fourth locus for autosomal dominant hypercholesterolemia maps at 16q22.1

J. Weissenbach, A. Munnich, C. Junien, 2010, European Journal of Human Genetics.

Identification of the first Lebanese mutation in the LPL gene and description of a rapid detection method

C. Junien, E. Chouery, C. Boileau, 2004, Clinical genetics.

Regional mapping of liver type 6 phosphofructokinase isoenzyme on chromosome 21

M. Rethoré, D. Allard, B. Chadefaux, 2004, Human Genetics.

Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma

N. Sonenberg, A. Eggermont, J. Adam, 2018, Nature Medicine.

MET functions in tumour progression and therapy resistance are repressed by intronic polyadenylation

Céline M. Labbé, P. Gestraud, S. Vacher, 2023, bioRxiv.